Abstract
BackgroundThe consequences of opioids—including post-surgical prescriptions—remain a critical public health issue. We sought to determine how procedure type and subspecialty group influence new opioid use after procedures. MethodsWe analyzed 2011–2015 IBM MarketScan Research Databases to identify opioid-naïve adults prescribed opioids for single surgical procedures. We defined new opioid continuation (primary outcome) a priori as receipt of prescription opioids between 90 and 180 days after the procedure. ResultsAmong 912,882 individuals, new opioid continuation was higher for non-operating room compared to operating room procedures (13.1% versus 9.2%; aOR 1.61; 95% CI 1.59–1.64) and higher for subspecialties including colorectal surgery (aOR 1.35; 95% CI 1.26–1.43) and cardiovascular surgery (aOR 1.30; 95% CI 1.12–1.50) compared to urology as a referent. New opioid continuation was also associated with perioperative opioid prescription dosage, days’ supply, preoperative receipt, and multiple prescriptions. ConclusionsOpioids prescriptions associated with non-operating room surgical exposures appear to confer higher risk regarding conversion to new long-term opioid use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.